Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Status: Enrolling
Updated:  9/18/2013
Dartmouth Medical Center
mi
from
Lebanon, NH
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Status: Enrolling
Updated: 9/18/2013
Dartmouth Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Status: Enrolling
Updated:  9/18/2013
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Status: Enrolling
Updated: 9/18/2013
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Status: Enrolling
Updated:  9/18/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Status: Enrolling
Updated: 9/18/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Status: Enrolling
Updated:  9/21/2013
Commonwealth Hematology-Oncology
mi
from
Lawrence, MA
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Status: Enrolling
Updated: 9/21/2013
Commonwealth Hematology-Oncology
mi
from
Lawrence, MA
Click here to add this to my saved trials
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.
Status: Enrolling
Updated:  9/30/2013
Hillman Cancer Center
mi
from
Pittsburgh, PA
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.
Status: Enrolling
Updated: 9/30/2013
Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated:  9/30/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated: 9/30/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated:  9/30/2013
Weill Cornell Breast Center
mi
from
New York, NY
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated: 9/30/2013
Weill Cornell Breast Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated:  9/30/2013
Beth Israel Medical Center, Comprehensive Cancer Center
mi
from
New York, NY
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated: 9/30/2013
Beth Israel Medical Center, Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated:  9/30/2013
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia
Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer
Status: Enrolling
Updated: 9/30/2013
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study
Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study
Status: Enrolling
Updated:  10/11/2013
Stanford University Cancer Institute
mi
from
Stanford, CA
Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study
Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study
Status: Enrolling
Updated: 10/11/2013
Stanford University Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
MRI Evaluation of the Breast Areolar Margin and Paryenchyma
MRI Evaluation to Assess the Relationship Between the Areolar Margin and Underlying Breast Paryenchyma Attachments to the Dermis
Status: Enrolling
Updated:  10/19/2013
Piedmont Hospital
mi
from
Atlanta, GA
MRI Evaluation of the Breast Areolar Margin and Paryenchyma
MRI Evaluation to Assess the Relationship Between the Areolar Margin and Underlying Breast Paryenchyma Attachments to the Dermis
Status: Enrolling
Updated: 10/19/2013
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin in Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  10/21/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin in Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 10/21/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of the CYP1A2 Inhibitor, Fluvoxamine, on Dovitinib (TKI258) Pharmacokinetics in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  11/6/2013
Washington University School Of Medicine-Siteman Cancer Ctr Wash Univ
mi
from
St. Louis, MO
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of the CYP1A2 Inhibitor, Fluvoxamine, on Dovitinib (TKI258) Pharmacokinetics in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 11/6/2013
Washington University School Of Medicine-Siteman Cancer Ctr Wash Univ
mi
from
St. Louis, MO
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of the CYP1A2 Inhibitor, Fluvoxamine, on Dovitinib (TKI258) Pharmacokinetics in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  11/6/2013
Montefiore Medical Center Montefiore Medical Center (SC)
mi
from
Bronx, NY
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of the CYP1A2 Inhibitor, Fluvoxamine, on Dovitinib (TKI258) Pharmacokinetics in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 11/6/2013
Montefiore Medical Center Montefiore Medical Center (SC)
mi
from
Bronx, NY
Click here to add this to my saved trials
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of the CYP1A2 Inhibitor, Fluvoxamine, on Dovitinib (TKI258) Pharmacokinetics in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  11/6/2013
Cancer Therapy & Research Center / UT Health Science Center SC
mi
from
San Antonio, TX
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of the CYP1A2 Inhibitor, Fluvoxamine, on Dovitinib (TKI258) Pharmacokinetics in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 11/6/2013
Cancer Therapy & Research Center / UT Health Science Center SC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Jacksonville, FL
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Detroit, MI
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Billings, MT
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Middletown, OH
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Middletown, OH
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Greenville, SC
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Germantown, TN
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Dallas, TX
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated:  11/13/2013
Clinical Research Facility
mi
from
Spokane, WA
Adenoviral Vector Monotherapy or Combination With Chemotherapy Study in Subjects With Recurrent/Metastatic Breast Cancer and Accessible/Visible Lesions
A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide-Tris in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions
Status: Enrolling
Updated: 11/13/2013
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated:  11/29/2013
Pinnacle Oncology Hematology; 9055 East Del Camino
mi
from
Scottsdale, AZ
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated: 11/29/2013
Pinnacle Oncology Hematology; 9055 East Del Camino
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated:  11/29/2013
University of Kansas Medical Center; 4350 Shawnee Mission Parkway
mi
from
Fairway, KA
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated: 11/29/2013
University of Kansas Medical Center; 4350 Shawnee Mission Parkway
mi
from
Fairway, KA
Click here to add this to my saved trials
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated:  11/29/2013
University of Michigan; 1500 East Medical Center Drive
mi
from
Ann Arbor, MI
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated: 11/29/2013
University of Michigan; 1500 East Medical Center Drive
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated:  11/29/2013
Fox Chase Cancer Center; 333 Cottman Avenue
mi
from
Philadelphia, PA
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated: 11/29/2013
Fox Chase Cancer Center; 333 Cottman Avenue
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated:  11/29/2013
Thomas Jefferson University Hospital; 1025 Walnut Street
mi
from
Philadelphia, PA
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated: 11/29/2013
Thomas Jefferson University Hospital; 1025 Walnut Street
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated:  11/29/2013
University of Pittsburgh; 300 Halket Street
mi
from
Pittsburgh, PA
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Status: Enrolling
Updated: 11/29/2013
University of Pittsburgh; 300 Halket Street
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Status: Enrolling
Updated:  12/16/2013
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Status: Enrolling
Updated: 12/16/2013
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study
Status: Enrolling
Updated:  1/6/2014
Queens Cancer Center of Queens Hospital
mi
from
Jamaica, NY
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 1/6/2014
Queens Cancer Center of Queens Hospital
mi
from
Jamaica, NY
Click here to add this to my saved trials
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study
Status: Enrolling
Updated:  1/6/2014
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer
Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 1/6/2014
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer
NCI 8701: A Pilot Study Utilizing C11 Alpha Methyl Tryptophan (AMT) PET Functional Imaging in Patients With Metastatic Invasive Breast Cancer Treated With 1 Methyl D Tryptophan Plus the Ad p53 DC Vaccine
Status: Enrolling
Updated:  1/7/2014
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer
NCI 8701: A Pilot Study Utilizing C11 Alpha Methyl Tryptophan (AMT) PET Functional Imaging in Patients With Metastatic Invasive Breast Cancer Treated With 1 Methyl D Tryptophan Plus the Ad p53 DC Vaccine
Status: Enrolling
Updated: 1/7/2014
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast Cancer
Identification and Differentiation of Breast Masses by Vibro-Acoustography
Status: Enrolling
Updated:  1/8/2014
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast Cancer
Identification and Differentiation of Breast Masses by Vibro-Acoustography
Status: Enrolling
Updated: 1/8/2014
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound
2D Silicon Transducer-Compression Plates for Breast Ultrasound
Status: Enrolling
Updated:  1/16/2014
University of Michigan
mi
from
Ann Arbor, MI
Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound
2D Silicon Transducer-Compression Plates for Breast Ultrasound
Status: Enrolling
Updated: 1/16/2014
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
Status: Enrolling
Updated:  2/18/2014
Michigan Center for Oral Health Research (MCOHR)
mi
from
Ann Arbor, MI
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
Status: Enrolling
Updated: 2/18/2014
Michigan Center for Oral Health Research (MCOHR)
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Status: Enrolling
Updated:  2/20/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Status: Enrolling
Updated: 2/20/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Mammaglobin-A DNA Vaccine in Breast Cancer Patients With Metastatic Disease
Status: Enrolling
Updated:  2/27/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Mammaglobin-A DNA Vaccine in Breast Cancer Patients With Metastatic Disease
Status: Enrolling
Updated: 2/27/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated:  3/4/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated: 3/4/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated:  3/4/2014
UK Center for Clinical and Translational Science
mi
from
Lexington, KY
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated: 3/4/2014
UK Center for Clinical and Translational Science
mi
from
Lexington, KY
Click here to add this to my saved trials
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated:  3/4/2014
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
A Pilot Study of Working Women and Breast Cancer
A Pilot Study of Working Women and Breast Cancer
Status: Enrolling
Updated: 3/4/2014
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Pectoral Nerve Blockade in Mastectomy
Improvement of Analgesia With Addition of Pectoral Nerve Block to Thoracic Paravertebral Blocks in Unilateral Total Simple Mastectomy
Status: Enrolling
Updated:  3/12/2014
The University of New Mexico Hospital
mi
from
Albuquerque, NM
Pectoral Nerve Blockade in Mastectomy
Improvement of Analgesia With Addition of Pectoral Nerve Block to Thoracic Paravertebral Blocks in Unilateral Total Simple Mastectomy
Status: Enrolling
Updated: 3/12/2014
The University of New Mexico Hospital
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Baylor College of Medicine Dept of Oncology
mi
from
Houston, TX
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Baylor College of Medicine Dept of Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5)
mi
from
San Antonio, TX
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5)
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Cedars Sinai Medical Center SC
mi
from
Los Angeles, CA
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Cedars Sinai Medical Center SC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC
mi
from
Tampa, FL
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC
mi
from
Tampa, FL
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Massachusetts General Hospital Mass General 2
mi
from
Boston, MA
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Massachusetts General Hospital Mass General 2
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Memorial Sloan Kettering Cancer Center Dept of Onc
mi
from
New York, NY
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Memorial Sloan Kettering Cancer Center Dept of Onc
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/27/2014
Ohio State Comprehensive Cancer Center/James Cancer Hospital Ohio State
mi
from
Columbus, OH
A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/27/2014
Ohio State Comprehensive Cancer Center/James Cancer Hospital Ohio State
mi
from
Columbus, OH
Click here to add this to my saved trials